Corporate GovernanceMay 28, 2026, 01:21 PM
Dr. Reddy's Files Annual Secretarial Compliance Report for FY26
AI Summary
Dr. Reddy's Laboratories Ltd. has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, prepared by Makarand M. Joshi & Co., confirms that the company has complied with all applicable SEBI Regulations, circulars, and guidelines, including the Listing Regulations and Prohibition of Insider Trading Regulations. No deviations or non-compliances were observed during the review period, and all related party transactions received prior audit committee approval.
Key Highlights
- Dr. Reddy's Laboratories filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
- The report confirms compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The company complied with applicable Secretarial Standards issued by ICSI.
- All applicable policies under SEBI Regulations were adopted, reviewed, and timely updated.
- The company maintains a functional website with timely dissemination of information.
- No directors were disqualified under Section 164 of the Companies Act, 2013.
- All Related Party Transactions received prior approval from the Audit Committee.
- No actions were taken against the company by SEBI or Stock Exchanges during the review period.
Price Impact
More from RDY